Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Multi-Omics Assessment of Genetic Risk for Celiac Disease in Down Syndrome

Marisa Gallant Stahl, Jessica R Shaw, Neetha Paul Eduthan, Angela L Rachubinski, Keith P Smith, Belinda Enriquez Estrada, Matthew D Galbraith, Ronald J Sokol, Sameer Chavan, Laura Ann Leaton, Katherine M Kichula, Paul J Norman, Jill M Norris, Edwin Liu, View ORCID ProfileJoaquin M Espinosa
doi: https://doi.org/10.1101/2022.09.27.22280436
Marisa Gallant Stahl
1Digestive Health Institute, Children’s Hospital Colorado, Department of Pediatrics, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States
2Linda Crnic Institute for Down Syndrome, University of Colorado, Aurora, CO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jessica R Shaw
2Linda Crnic Institute for Down Syndrome, University of Colorado, Aurora, CO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neetha Paul Eduthan
2Linda Crnic Institute for Down Syndrome, University of Colorado, Aurora, CO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Angela L Rachubinski
2Linda Crnic Institute for Down Syndrome, University of Colorado, Aurora, CO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keith P Smith
2Linda Crnic Institute for Down Syndrome, University of Colorado, Aurora, CO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Belinda Enriquez Estrada
2Linda Crnic Institute for Down Syndrome, University of Colorado, Aurora, CO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew D Galbraith
2Linda Crnic Institute for Down Syndrome, University of Colorado, Aurora, CO
3Department of Pharmacology, University of Colorado Anschutz Medical Campus
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ronald J Sokol
1Digestive Health Institute, Children’s Hospital Colorado, Department of Pediatrics, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sameer Chavan
4Department of Biomedical Informatics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura Ann Leaton
4Department of Biomedical Informatics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
5Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katherine M Kichula
4Department of Biomedical Informatics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
5Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul J Norman
4Department of Biomedical Informatics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
5Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jill M Norris
6Department of Epidemiology, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edwin Liu
1Digestive Health Institute, Children’s Hospital Colorado, Department of Pediatrics, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joaquin M Espinosa
2Linda Crnic Institute for Down Syndrome, University of Colorado, Aurora, CO
3Department of Pharmacology, University of Colorado Anschutz Medical Campus
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joaquin M Espinosa
  • For correspondence: joaquin.espinosa@cuanschutz.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Objectives Individuals with Down syndrome (DS) display high risk of celiac disease (CD), but the mechanisms underlying this increased susceptibility await elucidation. Here, we examined the prevalence of HLA genotypes associated with CD risk in the general population and tested a previously developed genetic risk score (GRS) for CD in people with DS.

Methods HLA genotypes were obtained for 204 individuals with DS in the Human Trisome Project cohort study, of whom 9% had CD. We compared HLA genotype frequencies in those with and without CD against frequencies observed in the general population. CD permissive HLA haplotypes explored were DQ2.5, DQ2.2, DQ8.1, and DQ7.5. We also analyzed 38 non-HLA-DQ alleles used to generate the CD GRS.

Results Frequencies of risk genotypes were different for CD in DS versus CD in the general population. For example, we observed lower frequency of DQ2.5/DQ2.5 and higher prevalence of DQ7.5/X and X/X in CD in DS. Although GRS values were significantly increased in those with CD and DS, their predictive power was decreased relative to the general population. Transcriptome analysis revealed dysregulated expression of many genes composing the GRS in DS. Proteomics analysis showed that GRS values correlate with elevation of specific immune factors in DS.

Conclusions The genetic risk profile of CD in DS is different relative to the general population, which is likely due to dysregulation of immune pathways in DS. Larger studies are needed to elucidate pathogenic mechanisms and to develop a validated GRS for CD in DS.

What is Known

  • Celiac disease is more common in individuals with Down syndrome, but the impact of HLA risk genotypes in this population is unclear.

  • A celiac disease genetic risk score incorporating HLA-DQ and non-HLA SNPs has been developed with good predictive accuracy in the general population.

What is New

  • Individuals with DS may still develop CD even without the traditional HLA-DQ risk factors.

  • A modified CD genetic risk score may be applied to individuals with DS with good accuracy and specificity.

  • The immune dysregulation characteristic of DS involves dysregulated expression of many genes involved in CD etiology.

Competing Interest Statement

R.J.S. serves on the advisory committee for Mirum Pharma and Abireo Pharma and is a consultant for Astellas.

Funding Statement

This study was funded by the NIH Office of the Director via the NIH INCLUDE Project through NIAID grant R01AI150305, and NCATS grants 5UL1TR002535 and KL2-TR002534. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Additional funding was provided by the Linda Crnic Institute for Down Syndrome, the GLOBAL Down Syndrome Foundation, the Anna and John J. Sie Foundation, the GI & Liver Innate Immune Program, the Human Immunology and Immunotherapy Initiative, and the University of Colorado School of Medicine.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Colorado Multiple Institutional Review Board (COMIRB) gave ethical approval of this work under protocol numbers COMIRB# 15-2170 and COMIRB# 20-1977. See also clinicaltrials.gov entry NCT02864108.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors

  • Abbreviations

    (CD)
    Celiac Disease
    (D21)
    Disomy 21
    (DS)
    Down Syndrome
    (GRS)
    Genetic Risk Score
    (HLA)
    Human Leukocyte Antigen
    (IFN)
    Interferon
    (T21)
    Trisomy 21
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted September 29, 2022.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Multi-Omics Assessment of Genetic Risk for Celiac Disease in Down Syndrome
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Multi-Omics Assessment of Genetic Risk for Celiac Disease in Down Syndrome
    Marisa Gallant Stahl, Jessica R Shaw, Neetha Paul Eduthan, Angela L Rachubinski, Keith P Smith, Belinda Enriquez Estrada, Matthew D Galbraith, Ronald J Sokol, Sameer Chavan, Laura Ann Leaton, Katherine M Kichula, Paul J Norman, Jill M Norris, Edwin Liu, Joaquin M Espinosa
    medRxiv 2022.09.27.22280436; doi: https://doi.org/10.1101/2022.09.27.22280436
    Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
    Citation Tools
    Multi-Omics Assessment of Genetic Risk for Celiac Disease in Down Syndrome
    Marisa Gallant Stahl, Jessica R Shaw, Neetha Paul Eduthan, Angela L Rachubinski, Keith P Smith, Belinda Enriquez Estrada, Matthew D Galbraith, Ronald J Sokol, Sameer Chavan, Laura Ann Leaton, Katherine M Kichula, Paul J Norman, Jill M Norris, Edwin Liu, Joaquin M Espinosa
    medRxiv 2022.09.27.22280436; doi: https://doi.org/10.1101/2022.09.27.22280436

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Gastroenterology
    Subject Areas
    All Articles
    • Addiction Medicine (215)
    • Allergy and Immunology (495)
    • Anesthesia (106)
    • Cardiovascular Medicine (1095)
    • Dentistry and Oral Medicine (195)
    • Dermatology (141)
    • Emergency Medicine (274)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (500)
    • Epidemiology (9764)
    • Forensic Medicine (5)
    • Gastroenterology (480)
    • Genetic and Genomic Medicine (2304)
    • Geriatric Medicine (222)
    • Health Economics (462)
    • Health Informatics (1555)
    • Health Policy (734)
    • Health Systems and Quality Improvement (603)
    • Hematology (236)
    • HIV/AIDS (503)
    • Infectious Diseases (except HIV/AIDS) (11637)
    • Intensive Care and Critical Care Medicine (616)
    • Medical Education (237)
    • Medical Ethics (67)
    • Nephrology (257)
    • Neurology (2140)
    • Nursing (134)
    • Nutrition (336)
    • Obstetrics and Gynecology (426)
    • Occupational and Environmental Health (517)
    • Oncology (1174)
    • Ophthalmology (364)
    • Orthopedics (128)
    • Otolaryngology (220)
    • Pain Medicine (145)
    • Palliative Medicine (50)
    • Pathology (310)
    • Pediatrics (694)
    • Pharmacology and Therapeutics (299)
    • Primary Care Research (266)
    • Psychiatry and Clinical Psychology (2179)
    • Public and Global Health (4653)
    • Radiology and Imaging (775)
    • Rehabilitation Medicine and Physical Therapy (457)
    • Respiratory Medicine (623)
    • Rheumatology (274)
    • Sexual and Reproductive Health (225)
    • Sports Medicine (210)
    • Surgery (250)
    • Toxicology (43)
    • Transplantation (120)
    • Urology (94)